Enbrel reimbursable for ankylosing spondylitis.

Enbrel injection of Wyeth Korea has been approved of its NHI reimbursement for the indication of ankylosing spondylitis effective from May. Now, the portion of patient's payment for Enbrel has been cut down to 260 thousand won from 1,310 thousand won.

Ankylosing spondylitis is a chronic inflammation disorder occurred in the spinal cord and about 0.1 to 0.2% of the total Korean population su...